Physician profile
George Christopher Leef
NPI 1831584010
$5,762.03
in general payments reported to CMS, 2019-2025
25 companies · $168 in 2025
The $168 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $257 · 2021: $2,004 · 2022: $2,153 · 2023: $686 · 2024: $494 · 2025: $168.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,348.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,348.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Siemens Medical Solutions USA, INC. | $1,163.09 | 2021 | |
| Janssen Pharmaceuticals, INC | $1,105.33 | 2021-2022 | |
| Novo Nordisk INC | $474.46 | 2021-2024 | Wegovy, Ozempic, Rybelsus |
| Boehringer Ingelheim Pharmaceuticals, INC. | $392.91 | 2021-2024 | Jardiance |
| Novartis Pharmaceuticals Corporation | $366.49 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $297.63 | 2019-2025 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $296.18 | 2019-2022 | |
| Boston Scientific Corporation | $286.72 | 2021-2023 | Watchman Flx |
| Pfizer INC. | $202.52 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $173.15 | 2021-2022 | |
| Philips North America LLC | $170.42 | 2022-2025 | Holter, (Ck7) Extended Holter, Extended Holter |
| Amgen INC. | $137.46 | 2022-2024 | |
| Edwards Lifesciences Corporation | $135.00 | 2024 | |
| Ge Healthcare | $125.00 | 2023 | |
| Alnylam Pharmaceuticals INC. | $117.19 | 2024 | Amvuttra |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $101.81 | 2022 | |
| Esperion Therapeutics, INC. | $36.41 | 2021-2022 | |
| Kowa Pharmaceuticals America, INC. | $27.25 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $27.25 | 2022 | |
| Cardiva Medical, INC. | $26.97 | 2021 | |
| Irhythm Technologies, INC. | $21.91 | 2023 | Zio Xt Patch |
| Exact Sciences Corporation | $21.73 | 2023 | Cologuard Collection Kit |
| Abbott Laboratories | $20.02 | 2022 | |
| Amarin Pharma, INC. | $18.20 | 2022 | |
| Abbvie INC. | $16.93 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Leef listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.